Evaluation of Cardiac Variability After a Vitamine D Protocol and Whole Body Vibration

Aging Clinical Trial

Official title:

Heart Rate Variability in Healthy Older and Older COPD After Vitamine D Use and Whole Body Vibration Protocol

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03679325
• Other study ID #: COPDcardiac variability
• Status: Active, not recruiting
• Phase: N/A
• Start date: May 20, 2018
• Est. completion date: September 30, 2018

Study information

• Verified date: September 2018
• Source: Universidade Federal de Pernambuco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of heart rate variability in time and frequency domains, in Chronic Obstructive Pulmonary Disease (COPD) after 03 months of vitamine D supplementation and whole body vibration (WBV) training

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 59
• Est. completion date: September 30, 2018
• Est. primary completion date: August 30, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years to 75 Years

Eligibility

Inclusion Criteria:

• COPD or healthy elderly sedentary according to International Physical Activity Questionnaire

• BMI between 22.9 and 28 kg/m2

• COPD with clinical-functional diagnosis of the disease according to Gold

• ex-smokers

Exclusion Criteria:

• Older patients with COPD who had episodes of exacerbation in the last three months

• Who participate in pulmonary rehabilitation programs in the last year

• Who used home oxygen therapy

• Patients with COPD-associated comorbidities

• Who were taking vitamin D

Related Conditions & MeSH terms

• Aging
• Copd

Intervention

Dietary Supplement:
• vitamine D
a dose once a week

Other:
• whole body vibration (WBV)
03 months of WBV training three times per week

Locations

Country	Name	City	State
Brazil	Federal University of Pernambuco	Recife	Pernambuco

Sponsors (1)

Lead Sponsor	Collaborator
Maíra F Pessoa

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	heart rate variability	evaluation of time and frequency domains	before and immediately after the chronic intervention